As of the 6th of February, HLS Therapeutics retains the risk adjusted performance of (0.14), and Market Risk Adjusted Performance of 0.4593. HLS Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as HLS, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HLS
HLS
HLS Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Please note, there is a significant difference between HLS Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if HLS Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, HLS Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.
HLS Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HLS Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HLS Therapeutics.
0.00
11/08/2025
No Change 0.00
0.0
In 2 months and 31 days
02/06/2026
0.00
If you would invest 0.00 in HLS Therapeutics on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding HLS Therapeutics or generate 0.0% return on investment in HLS Therapeutics over 90 days. HLS Therapeutics is related to or competes with Cannara Biotech, Cardiol Therapeutics, Auxly Cannabis, Helix BioPharma, Biosyent, and Quipt Home. HLS Therapeutics Inc., a specialty pharmaceutical company, focuses on acquiring and commercializing pharmaceutical produ... More
HLS Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HLS Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HLS Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for HLS Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HLS Therapeutics' standard deviation. In reality, there are many statistical measures that can use HLS Therapeutics historical prices to predict the future HLS Therapeutics' volatility.
HLS Therapeutics holds Efficiency (Sharpe) Ratio of -0.16, which attests that the entity had a -0.16 % return per unit of volatility over the last 3 months. HLS Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out HLS Therapeutics' market risk adjusted performance of 0.4593, and Risk Adjusted Performance of (0.14) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.67, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning HLS Therapeutics are expected to decrease at a much lower rate. During the bear market, HLS Therapeutics is likely to outperform the market. At this point, HLS Therapeutics has a negative expected return of -0.25%. Please make sure to check out HLS Therapeutics' skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if HLS Therapeutics performance from the past will be repeated at future time.
Auto-correlation
0.29
Poor predictability
HLS Therapeutics has poor predictability. Overlapping area represents the amount of predictability between HLS Therapeutics time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HLS Therapeutics price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current HLS Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.29
Spearman Rank Test
0.2
Residual Average
0.0
Price Variance
0.01
HLS Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of HLS Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of HLS Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
HLS Therapeutics Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of HLS Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About HLS Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of HLS Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of HLS Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on HLS Therapeutics price pattern first instead of the macroeconomic environment surrounding HLS Therapeutics. By analyzing HLS Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of HLS Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to HLS Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
HLS Therapeutics February 6, 2026 Technical Indicators
Most technical analysis of HLS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for HLS from various momentum indicators to cycle indicators. When you analyze HLS charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
HLS Therapeutics February 6, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as HLS stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
HLS Therapeutics financial ratios help investors to determine whether HLS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.